Plerixafor Can Predictably Mobilize Hematopoietic Stem Cells in Patients With Multiple Myeloma Previously Treated With LenalidomideStefano Tarantolo, D. Huebner, Gary Calandra et al.|Transplantation and Cellular Therapy|2009Cited by 3
Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple MyelomaSagar Lonial, Shaji Kumar, Stefano Tarantolo et al.|Blood|2021Cited by 3